Vasconcelos, D.; Chaves, B.; Albuquerque, A.; Andrade, L.; Henriques, A.; Sartori, G.; Savino, W.; Caffarena, E.; Martins-Da-Silva, J.H.
Development of New Potential Inhibitors of β1 Integrins through In Silico Methods—Screening and Computational Validation. Life 2022, 12, 932.
https://doi.org/10.3390/life12070932
AMA Style
Vasconcelos D, Chaves B, Albuquerque A, Andrade L, Henriques A, Sartori G, Savino W, Caffarena E, Martins-Da-Silva JH.
Development of New Potential Inhibitors of β1 Integrins through In Silico Methods—Screening and Computational Validation. Life. 2022; 12(7):932.
https://doi.org/10.3390/life12070932
Chicago/Turabian Style
Vasconcelos, Disraeli, Beatriz Chaves, Aline Albuquerque, Luca Andrade, Andrielly Henriques, Geraldo Sartori, Wilson Savino, Ernesto Caffarena, and João Herminio Martins-Da-Silva.
2022. "Development of New Potential Inhibitors of β1 Integrins through In Silico Methods—Screening and Computational Validation" Life 12, no. 7: 932.
https://doi.org/10.3390/life12070932
APA Style
Vasconcelos, D., Chaves, B., Albuquerque, A., Andrade, L., Henriques, A., Sartori, G., Savino, W., Caffarena, E., & Martins-Da-Silva, J. H.
(2022). Development of New Potential Inhibitors of β1 Integrins through In Silico Methods—Screening and Computational Validation. Life, 12(7), 932.
https://doi.org/10.3390/life12070932